US IPO news: Is ADARx Pharmaceuticals’ $446.3M Raise Worth It?
US IPO news reveals ADARx Pharmaceuticals raised $446.3 million in an upsized offering, showcasing strong investor interest.
IPO fundraising in India: Proven strategies for success
IPO fundraising in India is set to exceed Rs 1 lakh crore by 2026, presenting exciting opportunities for investors.
South Korea Stock Markets: Important Changes You Must Know
South Korea stock markets face important changes today. Discover the reasons behind the shift in timings and what it means for investors.